Page last updated: 2024-08-26

cilastatin and Pyrexia

cilastatin has been researched along with Pyrexia in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19905 (16.67)18.7374
1990's16 (53.33)18.2507
2000's7 (23.33)29.6817
2010's2 (6.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P1
Erdem, E; Gulec, SG; Kebudi, R; Vural, S; Yildirmak, Y1
Chochlakis, D; Ioannou, I; Psaroulaki, A; Tselentis, Y1
Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P1
Aoyagi, S; Hayashi, K; Horiuchi, H; Kawashima, Y; Kinoshita, H; Okuda, K; Shirouzu, K; Uchida, S; Yanase, A1
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C1
Allen, DM; Ang, PT; Au, E; Tow, A1
Eguchi, K; Kojima, A; Ohe, Y; Okamoto, H; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Soejima, Y; Tamura, T1
Barros, KV; Bianchi, A; Kusano, E; Melaragno, R; Petrilli, AS; Ribeiro, RC; Silva, AA1
Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M1
Deaney, NB; Tate, H1
Björkholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G1
Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM1
Gaya, H1
Garnache, F; Goffinet, P; Simon, M1
Abi-Said, D; Bodey, GP; Karl, CL; Raad, II; Rolston, KV1
Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M1
Başkan, S; Ozyilkan, O; Yalçintaş, U1
Anaissie, EJ; Gubbins, PO; McConnell, SA; Penzak, SR; Warmack, TS1
Briggs, A; Feldman, C; Flitcroft, A; O'Grady, J; Richards, G; White, H1
Arranz, R; de La Cámara, R; Font, P; Leyra, F; María Fernández Rañada, J; Pajuelo, F; Rivero, N1
Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT1
Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M1
Huijgens, PC; Langenhuijsen, MM; Ossenkoppele, GJ; Simoons-Smit, AM; van Loenen, AC; van Pampus, EC; Weijers, TF; Wijermans, PW1
Chan, TK; Chau, PY; Chiu, E; Lam, WK; Liang, R; Todd, D; Yung, R1
Liu, CY; Wang, FD1
Alvarez, ME; Bodey, GP; Elting, L; Fainstein, V; Jones, P; Rolston, K1
Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J1
Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Leedom, JM; Yellin, AE1
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L1

Reviews

1 review(s) available for cilastatin and Pyrexia

ArticleYear
A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:5

    Topics: Cilastatin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia; Protease Inhibitors; Thienamycins; Treatment Outcome

1996

Trials

20 trial(s) available for cilastatin and Pyrexia

ArticleYear
Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies

2010
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome

2004
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Current medical research and opinion, 2005, Volume: 21, Issue:5

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome

2005
Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
    Annals of the Academy of Medicine, Singapore, 1994, Volume: 23, Issue:6

    Topics: Antineoplastic Agents; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Costs and Cost Analysis; Drug Combinations; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Neutropenia; Sepsis

1994
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
    American journal of clinical oncology, 1994, Volume: 17, Issue:5

    Topics: Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome

1994
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Revista medica de Chile, 1995, Volume: 123, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins

1995
Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
    Journal of chemotherapy (Florence, Italy), 1996, Volume: 8, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Retreatment; Treatment Outcome

1996
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome

1997
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis

1998
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
    The Korean journal of internal medicine, 1999, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam

1999
An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia.
    International journal of antimicrobial agents, 2001, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Anti-Infective Agents; Cilastatin; Drug Administration Schedule; Female; Fever; Fluoroquinolones; Follow-Up Studies; Humans; Imipenem; Male; Middle Aged; Molecular Structure; Pneumonia; Protease Inhibitors; Thienamycins

2001
[Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
    Medicina clinica, 2001, May-05, Volume: 116, Issue:16

    Topics: Adolescent; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2001
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination

1992
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
    Japanese journal of clinical oncology, 1991, Volume: 21, Issue:6

    Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome

1991
Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.
    European journal of haematology, 1991, Volume: 46, Issue:1

    Topics: Antibiotics, Antineoplastic; Cilastatin; Drug Resistance, Microbial; Fever; Hematologic Diseases; Humans; Imipenem; Neutropenia; Time Factors

1991
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:7

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Prospective Studies; Randomized Controlled Trials as Topic

1990
A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients.
    Chemotherapy, 1989, Volume: 35 Suppl 2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Random Allocation; Remission Induction

1989
Imipenem/cilastatin therapy of infections in cancer patients.
    Cancer, 1987, Jul-15, Volume: 60, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Leukemia; Male; Middle Aged; Neoplasms; Pneumonia; Sepsis; Thienamycins

1987
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
    The American journal of medicine, 1988, Jul-25, Volume: 85, Issue:1A

    Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins

1988
Imipenem-cilastatin as initial therapy for febrile cancer patients.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:2

    Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins

1986

Other Studies

9 other study(ies) available for cilastatin and Pyrexia

ArticleYear
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
    Pharmacotherapy, 2009, Volume: 29, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors

2009
Human anaplasmosis and Anaplasma ovis variant.
    Emerging infectious diseases, 2010, Volume: 16, Issue:6

    Topics: Adult; Anaplasma ovis; Anaplasmosis; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bites and Stings; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyprus; DNA, Bacterial; Doxycycline; Drug Combinations; Female; Fever; Genes, Bacterial; Humans; Imipenem; Phylogeny; Ticks

2010
[A case of radiofrequency ablation therapy for recurrent hepatomas with tumor fever--efficacy of hepatic arterial infusion therapy with antibiotics and anticancer drugs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Cefmetazole; Cilastatin; Cisplatin; Female; Fever; Hepatic Artery; Humans; Imipenem; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Recurrence, Local

2004
Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
    The Pediatric infectious disease journal, 1993, Volume: 12, Issue:11

    Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neoplasms; Neutropenia

1993
Carbapenems in febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:5

    Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia

1997
[Primary peritonitis caused by Streptococcus pneumoniae].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1997, Volume: 26, Issue:6

    Topics: Abdominal Pain; Adult; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Cilastatin; Diarrhea; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Laparotomy; Penicillins; Peritonitis; Pneumococcal Infections; Protease Inhibitors; Puerperal Infection; Thienamycins; Treatment Outcome; Vagina

1997
How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
    Cancer, 1998, Jun-15, Volume: 82, Issue:12

    Topics: Adolescent; Adult; Aged; Cilastatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Protease Inhibitors; Retrospective Studies; Thienamycins; Treatment Outcome

1998
Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:6

    Topics: Adult; Aged; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Reactions; Drug Combinations; Drug Hypersensitivity; Fever; Humans; Imipenem; Incidence; Middle Aged; Neutropenia; Penicillins; Retrospective Studies

2000
Imipenem therapy for perforated and gangrenous appendicitis.
    Surgery, gynecology & obstetrics, 1986, Volume: 162, Issue:1

    Topics: Adult; Aged; Appendectomy; Appendicitis; Ascitic Fluid; Cilastatin; Clindamycin; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Gangrene; Gentamicins; Humans; Imipenem; Intestinal Perforation; Length of Stay; Middle Aged; Rupture, Spontaneous; Thienamycins

1986